Adapttech
Adapttech is a biomedical company focused on developing technologies that empower healthcare providers to help people with physical limitations to improve their quality of life. In 2018, Adapttech closed a €2.0 million investment round with Bionova Capital and Mercia Asset Management, an investor listed on the London Stock Exchange with £1bn under management.
Last updated on
About Adapttech
Estimated Revenue
$1M-$10MFunding / Mkt. Cap
$8MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
BirminghamState
West MidlandsCountry
United KingdomAdapttech
Find your buyer within Adapttech